News + Filings Holdings
All
13F
13D/G
Other
|
|
Broadfin Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2019 |
SC 13G
| Broadfin Capital, LLC reports a 5% stake in Retrophin, Inc. |
| 06/14/2019 |
SC 13G
| Broadfin Capital, LLC reports a 6.8% stake in Eiger BioPharmaceuticals, Inc. |
| 02/11/2019 |
SC 13G
| Broadfin Capital, LLC reports a 7.4% stake in Egalet Corporation |
| 01/29/2019 |
SC 13G
| Broadfin Capital, LLC reports a 5.6% stake in Aclaris Therapeutics, Inc. |
| 01/03/2019 |
SC 13G
| Broadfin Capital, LLC reports a 5.3% stake in Neos Therapeutics, Inc. |
| 09/07/2018 |
SC 13G
| Broadfin Capital, LLC reports a 5.5% stake in Sierra Oncology, Inc. |
| 06/11/2018 |
SC 13G
| Broadfin Capital, LLC reports a 7.2% stake in ADMA Biologics, Inc. |
| 05/01/2018 |
SC 13G
| Broadfin Capital, LLC reports a 5.6% stake in Teligent, Inc. |
| 04/24/2018 |
SC 13G
| Broadfin Capital, LLC reports a 5.4% stake in Adamas Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G
| Broadfin Capital, LLC reports a 6.8% stake in Iovance Biotherapeutics, Inc. |
| 02/13/2018 |
SC 13G
| Broadfin Capital, LLC reports a 0% stake in Arcturus Therapeutics Ltd. |
| 01/11/2018 |
SC 13G
| Broadfin Capital, LLC reports a 5% stake in La Jolla Pharmaceutical Company |
| 01/03/2018 |
SC 13G
| Broadfin Capital, LLC reports a 10% stake in Egalet Corporation |
| 07/24/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/13/2017 |
SC 13G
| Broadfin Capital, LLC reports a 5.3% stake in Cidara Therapeutics, Inc. |
| 03/29/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/10/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/10/2017 |
SC 13G
| Broadfin Capital, LLC reports a 10% stake in Dextera Surgical, Inc. |
| 01/09/2017 |
SC 13G
| Mirati Therapeutics, Inc. reports a 6.9% stake in Mirati Therapeutics, Inc. |
| 01/06/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/21/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/04/2016 |
SC 13G
| Broadfin Capital, LLC reports a 5.8% stake in Veracyte, Inc. |
| 08/10/2016 |
SC 13G
| Mirati Therapeutics, Inc. reports a 5% stake in Mirati Therapeutics, Inc. |
| 03/24/2016 |
SC 13G
| Aralez Pharmaceuticals Inc. reports a 5.9% stake in Aralez Pharmaceuticals Inc. |
| 03/01/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/17/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/04/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/14/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/27/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/27/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/19/2013 |
SC 13G
| RXi Pharmaceuticals Corp reports a 9.6% stake in RXi Pharmaceuticals Corporation |
| 03/19/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/11/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/28/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|
|